This track will explore the latest developments in gene therapy techniques aimed at treating inherited metabolic disorders in children. Emphasis will be placed on case studies and clinical trials demonstrating efficacy and safety.

This session will focus on the role of adipose tissue metabolism in the development of obesity and related metabolic disorders in children. Researchers will present findings on the molecular mechanisms and potential therapeutic targets.

This track will highlight the contributions of tandem mass spectrometry and other advanced diagnostic techniques in identifying lysosomal storage disorders in pediatric patients. Discussions will include challenges and future directions in diagnostic methodologies.

This session will address the comprehensive management of cardiometabolic diseases in children, including obesity, diabetes, and cardiovascular disorders. Experts will share evidence-based strategies and interventions tailored for pediatric care.

This track will delve into the complexities of endocrine disorders and diabetes management in pediatric populations. Presentations will cover recent research findings, clinical practices, and the impact of early intervention.

This session will investigate the metabolic side effects associated with antipsychotic drug use in pediatric patients, particularly focusing on obesity and diabetes. Researchers will discuss risk factors and management strategies.

This track will explore the role of dietary management in the treatment of various metabolic disorders in children. Presentations will highlight innovative dietary strategies and their impact on health outcomes.

This session will examine the mechanisms of energy homeostasis and how its disruption can lead to metabolic disorders in children. Researchers will discuss potential interventions to restore balance and promote health.

This track will focus on the genetic underpinnings of cardiovascular and metabolic disorders in pediatric populations. Presentations will highlight recent discoveries and their implications for diagnosis and treatment.

This session will address the intersection of digestive and metabolic diseases in children, exploring their causes, consequences, and management. Experts will share insights on improving patient outcomes through integrated care.

This track will showcase novel gene, cell, and molecular therapies being developed for inherited metabolic diseases in pediatrics. Discussions will focus on translational research and the future of therapeutic options.